209 related articles for article (PubMed ID: 16272632)
1. [Correlation of serum Bio-intact PTH (1-84) and parathyroid gland size in hemodialysed patients].
Inaba M; Imanishi Y; Ueda M; Cho H; Tahara H; Ishimura E; Nishizawa Y; Yamakawa T; Okuno S
Clin Calcium; 2005 Sep; 15 Suppl 1():64-6; discussion 66-7. PubMed ID: 16272632
[TBL] [Abstract][Full Text] [Related]
2. Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
Inaba M; Okuno S; Chou H; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Biomed Pharmacother; 2006 Feb; 60(2):62-5. PubMed ID: 16460905
[TBL] [Abstract][Full Text] [Related]
3. The relationship between total mass and blood supply of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Ahmadi F; Aghajanzadeh P; Yazdi HR; Maziar S; Gatmiri SM
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):263-9. PubMed ID: 26997379
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Kakuta T; Tanaka R; Kanai G; Miyamoto Y; Inagaki M; Suzuki H; Fukagawa M; Saito A
Ther Apher Dial; 2008 Oct; 12(5):385-90. PubMed ID: 18937722
[TBL] [Abstract][Full Text] [Related]
5. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
Inaba M; Okuno S; Imanishi Y; Ueda M; Yamakawa T; Ishimura E; Nishizawa Y
Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
[TBL] [Abstract][Full Text] [Related]
6. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
Kovács L; Virágh E; Balogh D; Kálmán B; Lőcsei Z; Toldy E
Orv Hetil; 2013 Dec; 154(51):2025-36. PubMed ID: 24334134
[TBL] [Abstract][Full Text] [Related]
8. Comparison between whole and intact parathyroid hormone assays.
Taniguchi M; Tanaka M; Hamano T; Nakanishi S; Fujii H; Kato H; Koiwa F; Ando R; Kimata N; Akiba T; Kono T; Yokoyama K; Shigematsu T; Kakuta T; Kazama JJ; Tominaga Y; Fukagawa M
Ther Apher Dial; 2011 Jun; 15 Suppl 1():42-9. PubMed ID: 21595852
[TBL] [Abstract][Full Text] [Related]
9. Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism.
Indridason OS; Heath H; Khosla S; Yohay DA; Quarles LD
Kidney Int; 1996 Nov; 50(5):1663-71. PubMed ID: 8914034
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient.
Komaba H; Takeda Y; Abe T; Komaba K; Otsuki N; Nibu K; Umezu M; Fukagawa M
Nephrol Dial Transplant; 2008 May; 23(5):1760-2. PubMed ID: 18079147
[No Abstract] [Full Text] [Related]
11. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
13. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism.
Ikeda Y; Kurihara H; Morita N; Miyabe R; Takami H
J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873
[TBL] [Abstract][Full Text] [Related]
14. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
Hida M
Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
[TBL] [Abstract][Full Text] [Related]
15. [Significance of point of no return in therapeutic strategy for treatment of renal osteodystrophy; from histopathological findings].
Koiwa F; Hirose M
Clin Calcium; 2004 Sep; 14(9):46-52. PubMed ID: 15577109
[TBL] [Abstract][Full Text] [Related]
16. Growth of parathyroid gland in uremic patients on maintenance hemodialysis.
Kawagishi T; Nishizawa Y; Emoto M; Kawasaki K; Shoji S; Inaba M; Miki T; Morita A; Tabata T; Inoue T
Miner Electrolyte Metab; 1995; 21(1-3):104-8. PubMed ID: 7565428
[TBL] [Abstract][Full Text] [Related]
17. A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.
Morita A; Tabata T; Koyama H; Emoto M; Inoue T; Miki T; Nishizawa Y; Morii H
Clin Nephrol; 1992 Sep; 38(3):154-7. PubMed ID: 1395169
[TBL] [Abstract][Full Text] [Related]
18. [Parathyroid gland intervention therapy for patients with secondary hyperparathyroidism due to dialysis].
Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
Clin Calcium; 2005 Sep; 15 Suppl 1():185-91. PubMed ID: 16279023
[No Abstract] [Full Text] [Related]
19. Calcium-mediated parathyroid hormone suppression test in uraemic secondary hyperparathyroidism.
Xiang T; Wang Y; Lan T; Zhou L
Nephrology (Carlton); 2021 Feb; 26(2):164-169. PubMed ID: 33058364
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
